Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospital.

Maisel WH, Kuntz KM, Reimold SC, Lee TH, Antman EM, Friedman PL, Stevenson WG.

Ann Intern Med. 1997 Aug 15;127(4):281-4.

PMID:
9265427
2.

Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.

Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J.

Am J Cardiol. 2003 Mar 20;91(6A):15D-26D. Review.

PMID:
12670638
3.

Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications.

Chung MK, Schweikert RA, Wilkoff BL, Niebauer MJ, Pinski SL, Trohman RG, Kidwell GA, Jaeger FJ, Morant VA, Miller DP, Tchou PJ.

J Am Coll Cardiol. 1998 Jul;32(1):169-76.

4.

Atrial fibrillation: rate control often better than rhythm control.

[No authors listed]

Prescrire Int. 2004 Apr;13(70):64-9.

PMID:
15148984
5.
6.

Arrhythmias in the intensive care patient.

Trappe HJ, Brandts B, Weismueller P.

Curr Opin Crit Care. 2003 Oct;9(5):345-55. Review.

PMID:
14508146
7.
8.

Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.

Singh SN, Tang XC, Reda D, Singh BN.

Heart Rhythm. 2009 Feb;6(2):152-5. doi: 10.1016/j.hrthm.2008.10.036. Epub 2008 Oct 29.

PMID:
19187902
9.

Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.

Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG.

J Am Coll Cardiol. 1992 Sep;20(3):527-32.

PMID:
1512329
10.

[Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].

Márk L, Erdej F, Dani G, Borbély M, Sziklai G, Nagy E, Hajdara I, Katona A.

Orv Hetil. 2004 May 9;145(19):1001-6. Hungarian.

PMID:
15181735
11.

Antiarrhythmic therapy and risk of death in patients with atrial fibrillation: a nationwide study.

Andersen SS, Hansen ML, Gislason GH, Schramm TK, Folke F, Fosbøl E, Abildstrøm SZ, Madsen M, Køber L, Torp-Pedersen C.

Europace. 2009 Jul;11(7):886-91. doi: 10.1093/europace/eup119. Epub 2009 May 14.

12.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

13.

Avoiding drug problems. The safety of drugs for supraventricular tachycardia.

Reimold SC.

Eur Heart J. 1997 May;18 Suppl C:C40-4. Review.

PMID:
9152674
14.

Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation.

Tuinenburg AE, Van Gelder IC, Van Den Berg MP, Brügemann J, De Kam PJ, Crijns HJ.

Heart. 1999 Oct;82(4):486-93.

16.

Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.

Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ, Ohman EM.

Card Electrophysiol Rev. 2003 Sep;7(3):201-7. Review.

PMID:
14739713
17.

Oral antiarrhythmic drugs in converting recent onset atrial fibrillation.

Deneer VH, Borgh MB, Kingma JH, Lie-A-Huen L, Brouwers JR.

Pharm World Sci. 2004 Apr;26(2):66-78. Review.

PMID:
15085940
18.

Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials.

Lafuente-Lafuente C, Mouly S, Longás-Tejero MA, Mahé I, Bergmann JF.

Arch Intern Med. 2006 Apr 10;166(7):719-28. Review.

PMID:
16606807
19.

Patterns and predictors of discontinuation of rhythm-control drug therapy in patients with newly diagnosed atrial fibrillation.

Kim MH, Klingman D, Lin J, Battleman DS.

Pharmacotherapy. 2009 Dec;29(12):1417-26. doi: 10.1592/phco.29.12.1417.

PMID:
19947801
Items per page

Supplemental Content

Write to the Help Desk